| Elizabeth Gallegos, CRNA | |
|
Naval Hospital Guantanamo Bay, Psc 1005 110000, Fpo, AA 34009 | |
| (757) 953-0972 | |
| Not Available |
| Full Name | Elizabeth Gallegos |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | Naval Hospital Guantanamo Bay, Fpo, Armed Forces Americas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306408786 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 122969 (Virgin Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Gallegos, CRNA Psc 1005 Box 110000, Fpo, AA 34009 Ph: () - | Elizabeth Gallegos, CRNA Naval Hospital Guantanamo Bay, Psc 1005 110000, Fpo, AA 34009 Ph: (757) 953-0972 |
News Archive
An enzyme that cancer cells eliminate, apparently so they can keep proliferating, may hold clues to more targeted, effective cancer treatment, scientists say.
Neuralstem, Inc. announced that it has filed an Investigational New Drug (IND) application with the United States Food and Drug Administration (FDA) to begin two Phase I safety trials to test NSI-189, its first small molecule compound, for the treatment of major depression. NSI-189 is a proprietary new chemical entity discovered by Neuralstem that stimulates new neuron growth in the hippocampus, an area of the brain that is believed to be involved in depression.
Myriad Genetics, Inc. today reported financial results for the third fiscal quarter and the nine-month period ended March 31, 2010.
Inadequate vaccine coverage is likely a driving force behind the ongoing Disneyland measles outbreak, according to calculations by a research team at Boston Children's Hospital.
› Verified 8 days ago